dc.contributor.author | Gautschi, Matthias | |
dc.contributor.author | Mayorandan, Sebene | |
dc.contributor.author | Meyer, Uta | |
dc.contributor.author | Segarra, Nuria Garcia | |
dc.contributor.author | de Baulny, Helene Ogier | |
dc.contributor.author | van Spronsen, Francjan | |
dc.contributor.author | Zeman, Jiri | |
dc.contributor.author | de laet, Corinne | |
dc.contributor.author | Spiekerkoetter, Ute | |
dc.contributor.author | Thimm, Eva | |
dc.contributor.author | Maiorana, Arianna | |
dc.contributor.author | Dionisi-Vici, Carlo | |
dc.contributor.author | Moeslinger, Dorothea | |
dc.contributor.author | Brunner-Krainz, Michaela | |
dc.contributor.author | Lotz-Havla, Amelie Sophia | |
dc.contributor.author | de Juan, Jose Angel Cocho | |
dc.contributor.author | Pico, Maria Luz Couce | |
dc.contributor.author | Santer, Rene | |
dc.contributor.author | Scholl-Buergi, Sabine | |
dc.contributor.author | Mandel, Hanna | |
dc.contributor.author | Bliksrud, Yngve Thomas | |
dc.contributor.author | Freisinger, Peter | |
dc.contributor.author | Aldamiz-Echevarria, Luis Jose | |
dc.contributor.author | Hochuli, Michel | |
dc.contributor.author | Endig, Jessica | |
dc.contributor.author | Jordan, Jens | |
dc.contributor.author | McKiernan, Patrick | |
dc.contributor.author | Ernst, Stefanie | |
dc.contributor.author | Morlot, Susanne | |
dc.contributor.author | Vogel, Arndt | |
dc.contributor.author | Sander, Johannes | |
dc.contributor.author | Das, Anibh Martin | |
dc.contributor.author | Gokcay, Gülden Fatma | |
dc.date.accessioned | 2021-03-04T11:19:31Z | |
dc.date.available | 2021-03-04T11:19:31Z | |
dc.identifier.citation | Mayorandan S., Meyer U., Gokcay G. F. , Segarra N. G. , de Baulny H. O. , van Spronsen F., Zeman J., de laet C., Spiekerkoetter U., Thimm E., et al., "Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice.", Orphanet journal of rare diseases, cilt.9, ss.107, 2014 | |
dc.identifier.issn | 1750-1172 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_71c9f876-8f95-4c0e-b671-60a686d0cddb | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/78340 | |
dc.identifier.uri | https://doi.org/10.1186/s13023-014-0107-7 | |
dc.description.abstract | Background: Hepatorenal tyrosinaemia (Tyr 1) is a rare inborn error of tyrosine metabolism. Without treatment, patients are at high risk of developing acute liver failure, renal dysfunction and in the long run hepatocellular carcinoma. The aim of our study was to collect cross-sectional data. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıbbi Genetik | |
dc.subject | Tıbbi Ekoloji ve Hidroklimatoloji | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Temel Bilimler | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | GENETİK VE HAYAT | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | TIP, ARAŞTIRMA VE DENEYSEL | |
dc.title | Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice. | |
dc.type | Makale | |
dc.relation.journal | Orphanet journal of rare diseases | |
dc.contributor.department | Hannover Medical School , , | |
dc.identifier.volume | 9 | |
dc.identifier.startpage | 107 | |
dc.identifier.endpage | 107 | |
dc.contributor.firstauthorID | 216083 | |